Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity

The high prevalence of preexisting immunity to adenovirus serotype 5 (Ad5) in human populations will likely limit the immunogenicity and clinical utility of recombinant Ad5 (rAd5) vector-based vaccines for human immunodeficiency virus type 1 and other pathogens. A potential solution to this problem...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lemckert, Angelique A. C., Sumida, Shawn M., Holterman, Lennart, Vogels, Ronald, Truitt, Diana M., Lynch, Diana M., Nanda, Anjali, Ewald, Bonnie A., Gorgone, Darci A., Lifton, Michelle A., Goudsmit, Jaap, Havenga, Menzo J. E., Barouch, Dan H.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2005
Assuntos:
Pathogenesis and Immunity
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1181575/
https://ncbi.nlm.nih.gov/pubmed/16014931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.15.9694-9701.2005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares